Mark Lackner
Biopharma executive| Drug developer| Precision Oncology Leader
- Role
- Scientific Advisor at Onc.Ai
- Location
- San Mateo, CA, US
- LinkedIn followers
- 500 followers
About Mark Lackner
Experienced drug development scientist and senior manager with over 25 years experience and substantial expertise in oncology drug development ranging from target identification through registrational clinical studies. Strong scientific leader with a passion for drug development and translational medicine.Strong publication record in Oncology with over 60 peer reviewed manuscripts.Specialties: Team leadership, discovery biology, biomarker and diagnostic development, oncology drug development, cancer biology, personalized medicine
Experience
Scientific Advisor
Sep 2021 — Present · San Carlos, CA, US
Provide strategic guidance on the utility of AI models to fulfill the potential of precision oncology and enable better patient outcomes
Education
Stanford University School of Medicine
PhD, Developmental Biology
1991 — 1997
University of California, Berkeley
Postdoctoral fellow, Molecular Genetics
1997 — 1999
University of Illinois Urbana-Champaign
BS, MS, Biology Honors
1985 — 1991
Skills
- Biomarkers
- Drug Discovery
- Cell Culture
- Personalized Medicine
- Lifesciences
- Biotechnology
- Team Leadership
- Cell Biology
- Biochemistry
- Oncology
- Translational Research
- Monoclonal Antibodies
- Immunology
- Assay Development
- Molecular Biology
- Biomarker Discovery
- Genetics
- Clinical Development
- Laboratory
- Drug Development
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.